Danaher Raised to Buy From Neutral by B of A Securities
Danaher Analyst Ratings
Jefferies Maintains Danaher(DHR.US) With Buy Rating, Cuts Target Price to $285
BofA Securities Upgrades Danaher(DHR.US) to Buy Rating, Maintains Target Price $290
RBC Trims Price Target on Danaher to $308 From $311, Keeps Outperform Rating
Wolfe Research Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $285
Danaher Analyst Ratings
Wolfe Research Upgrades Danaher(DHR.US) to Buy Rating, Announces Target Price $285
Danaher Is Maintained at Overweight by Keybanc
Danaher Price Target Raised to $310.00/Share From $290.00 by Keybanc
UBS Adjusts Price Target on Danaher to $305 From $309, Maintains Buy Rating
Danaher Analyst Ratings
Baird Maintains Outperform on Danaher, Lowers Price Target to $277
Danaher (DHR) Gets a Hold From Barclays
Goldman Sachs Raises Danaher's Price Target to $255 From $250
US stocks anomaly | danaher pre-market rise by 2.4%, JP Morgan raises its target price to $310.
Barclays Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $285
Barclays Sticks to Their Hold Rating for Danaher (DHR)
RBC Capital Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $333
J.P. Morgan Maintains Danaher(DHR.US) With Buy Rating, Raises Target Price to $310